Global Glyburide Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
1.25mg
2.5mg
5mg
Segment by Application
Pediatric Use
Geriatric Use
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR Sanjiu
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis

Table of Content
1 Glyburide Market Overview
1.1 Product Overview and Scope of Glyburide
1.2 Glyburide Segment by Type
1.2.1 Global Glyburide Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1.25mg
1.2.3 2.5mg
1.2.4 5mg
1.3 Glyburide Segment by Application
1.3.1 Glyburide Sales Comparison by Application: (2021-2027)
1.3.2 Pediatric Use
1.3.3 Geriatric Use
1.3.4 Others
1.4 Global Glyburide Market Size Estimates and Forecasts
1.4.1 Global Glyburide Revenue 2016-2027
1.4.2 Global Glyburide Sales 2016-2027
1.4.3 Glyburide Market Size by Region: 2016 Versus 2021 Versus 2027
2 Glyburide Market Competition by Manufacturers
2.1 Global Glyburide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Glyburide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Glyburide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Glyburide Manufacturing Sites, Area Served, Product Type
2.5 Glyburide Market Competitive Situation and Trends
2.5.1 Glyburide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glyburide Players Market Share by Revenue
2.5.3 Global Glyburide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glyburide Retrospective Market Scenario by Region
3.1 Global Glyburide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Glyburide Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Glyburide Market Facts & Figures by Country
3.3.1 North America Glyburide Sales by Country
3.3.2 North America Glyburide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glyburide Market Facts & Figures by Country
3.4.1 Europe Glyburide Sales by Country
3.4.2 Europe Glyburide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glyburide Market Facts & Figures by Region
3.5.1 Asia Pacific Glyburide Sales by Region
3.5.2 Asia Pacific Glyburide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Glyburide Market Facts & Figures by Country
3.6.1 Latin America Glyburide Sales by Country
3.6.2 Latin America Glyburide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glyburide Market Facts & Figures by Country
3.7.1 Middle East and Africa Glyburide Sales by Country
3.7.2 Middle East and Africa Glyburide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Glyburide Historic Market Analysis by Type
4.1 Global Glyburide Sales Market Share by Type (2016-2021)
4.2 Global Glyburide Revenue Market Share by Type (2016-2021)
4.3 Global Glyburide Price by Type (2016-2021)
5 Global Glyburide Historic Market Analysis by Application
5.1 Global Glyburide Sales Market Share by Application (2016-2021)
5.2 Global Glyburide Revenue Market Share by Application (2016-2021)
5.3 Global Glyburide Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amneal Pharmaceuticals
6.1.1 Amneal Pharmaceuticals Corporation Information
6.1.2 Amneal Pharmaceuticals Description and Business Overview
6.1.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amneal Pharmaceuticals Product Portfolio
6.1.5 Amneal Pharmaceuticals Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Corporation Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Aventis Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Jisheng Medicine
6.3.1 Jisheng Medicine Corporation Information
6.3.2 Jisheng Medicine Description and Business Overview
6.3.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Jisheng Medicine Product Portfolio
6.3.5 Jisheng Medicine Recent Developments/Updates
6.4 Double Whale Pharmaceutical
6.4.1 Double Whale Pharmaceutical Corporation Information
6.4.2 Double Whale Pharmaceutical Description and Business Overview
6.4.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Double Whale Pharmaceutical Product Portfolio
6.4.5 Double Whale Pharmaceutical Recent Developments/Updates
6.5 Bohai Pharmaceutical
6.5.1 Bohai Pharmaceutical Corporation Information
6.5.2 Bohai Pharmaceutical Description and Business Overview
6.5.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bohai Pharmaceutical Product Portfolio
6.5.5 Bohai Pharmaceutical Recent Developments/Updates
6.6 Sunlight Pharmaceutical
6.6.1 Sunlight Pharmaceutical Corporation Information
6.6.2 Sunlight Pharmaceutical Description and Business Overview
6.6.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sunlight Pharmaceutical Product Portfolio
6.6.5 Sunlight Pharmaceutical Recent Developments/Updates
6.7 Shapuaisi Pharma
6.6.1 Shapuaisi Pharma Corporation Information
6.6.2 Shapuaisi Pharma Description and Business Overview
6.6.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Shapuaisi Pharma Product Portfolio
6.7.5 Shapuaisi Pharma Recent Developments/Updates
6.8 CR Sanjiu
6.8.1 CR Sanjiu Corporation Information
6.8.2 CR Sanjiu Description and Business Overview
6.8.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CR Sanjiu Product Portfolio
6.8.5 CR Sanjiu Recent Developments/Updates
6.9 Physicians Total Care
6.9.1 Physicians Total Care Corporation Information
6.9.2 Physicians Total Care Description and Business Overview
6.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Physicians Total Care Product Portfolio
6.9.5 Physicians Total Care Recent Developments/Updates
6.10 Hoechst Canada
6.10.1 Hoechst Canada Corporation Information
6.10.2 Hoechst Canada Description and Business Overview
6.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Hoechst Canada Product Portfolio
6.10.5 Hoechst Canada Recent Developments/Updates
6.11 Apotex Corporation
6.11.1 Apotex Corporation Corporation Information
6.11.2 Apotex Corporation Glyburide Description and Business Overview
6.11.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Apotex Corporation Product Portfolio
6.11.5 Apotex Corporation Recent Developments/Updates
6.12 Avanstra
6.12.1 Avanstra Corporation Information
6.12.2 Avanstra Glyburide Description and Business Overview
6.12.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Avanstra Product Portfolio
6.12.5 Avanstra Recent Developments/Updates
6.13 Dominion Pharmacal
6.13.1 Dominion Pharmacal Corporation Information
6.13.2 Dominion Pharmacal Glyburide Description and Business Overview
6.13.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Dominion Pharmacal Product Portfolio
6.13.5 Dominion Pharmacal Recent Developments/Updates
6.14 Hikma Pharmaceuticals
6.14.1 Hikma Pharmaceuticals Corporation Information
6.14.2 Hikma Pharmaceuticals Glyburide Description and Business Overview
6.14.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Hikma Pharmaceuticals Product Portfolio
6.14.5 Hikma Pharmaceuticals Recent Developments/Updates
6.15 Cadila Pharmaceuticals
6.15.1 Cadila Pharmaceuticals Corporation Information
6.15.2 Cadila Pharmaceuticals Glyburide Description and Business Overview
6.15.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Cadila Pharmaceuticals Product Portfolio
6.15.5 Cadila Pharmaceuticals Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Glyburide Description and Business Overview
6.16.3 Novartis Glyburide Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Novartis Product Portfolio
6.16.5 Novartis Recent Developments/Updates
7 Glyburide Manufacturing Cost Analysis
7.1 Glyburide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glyburide
7.4 Glyburide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glyburide Distributors List
8.3 Glyburide Customers
9 Glyburide Market Dynamics
9.1 Glyburide Industry Trends
9.2 Glyburide Growth Drivers
9.3 Glyburide Market Challenges
9.4 Glyburide Market Restraints
10 Global Market Forecast
10.1 Glyburide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Glyburide by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Glyburide by Type (2022-2027)
10.2 Glyburide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glyburide by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Glyburide by Application (2022-2027)
10.3 Glyburide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glyburide by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Glyburide by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer